Abstract
We report a 3 year-old girl with a myoclonic epilepsy. A fatal hepatic failure occurred after 3 months of valproate (VPA) therapy. In this patient, a defect of cytochromec oxidase (COX) was demonstrated in her circulating lymphocytes. The enzyme was also found to be deficient in post-mortem liver and in cultured skin fibroblasts. However, a fully functional respiratory chain was found in muscle. VPA administration apparently triggered the hepatic failure, given this patient's background of partial COX deficiency.
Abbreviations
- COX :
-
cytochromec oxidase
- VPA :
-
valproate
References
Boustany RN, Aprille JR, Halperin J, Levy H, DeLong GR (1983) Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophtalmoplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol 14:462–470
Bremer HJ, Duran M, Kamerling JP, Przyrembel H, Wadman SK (1981) Disturbances of aminoacid metabolism: clinical chemistry and diagnosis. Urban and Schwarzenberg, Baltimore
Brown JK (1988) Valproate toxicity. Dev Med Child Neurol 30:121–125
Cormier V, Rustin P, Bonnefont JP, Rambaud C, Vassault A, Rabier D, Parvy P, Couderc S, Parrot-Roulaud F, Carré M, Risse JC, Cahuzac C, Saudubray JM, Rötig A, Hubert P, Munnich A (1991) Hepatic failure in disorders of oxidative phosphorylation with neonatal onset. J Pediatr 119: 951–954
Coulter DL (1991) Carnitine, valproate, and toxicity. J Child Neurol 6:7–14
Dreifuss FE, Langer DH, Moline KA, Maxwell JE (1989) Valproic acid hepatic fatalities. II. US experience since 1984. Neurology 39:201–207
Goodman SI, Markey SP (1981) Diagnosis of organic acidemias by gas chromatography-mass spectrometry. Laboratory and research methods in biology and medicine vol. 6. AR Liss, New York
Kondo T, Kaneko S, Otani K, Ishia M, Hirano T, Fukushima Y, Muranaka H, Koide N, Yokoyama M (1992) Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism. Epilepsia 33: 172–177
Merle P, Kadenbach B (1980) On the heterogeneity of the vertebrate cytochromec oxydase polypeptide chain composition. Hoppe-Seylers Z Physiol Chem 361:1257–1259
Munnich A, Rustin P, Rötig A, Chretien D, Bonnefont JP, Nuttin C, Cormier V, Vassault A, Parvy P, Bardet J, Charpentier C, Rabier D, Saudubray JM (1992) Clinical aspects of mitochondrial disorders. J Inherited Metab Dis 15:448–455
Parrot-Roulaud F, Carre M, Lamirau T, Letellier T, Malgat M, Mazat JP, Munnich A, Demarquez JL (1991) Fatal neonatal hepatocellular deficiency with lactic acidosis: a defect of the respiratory chain. J Inherited Metab Dis 14:289–292
Rettie AE, Rettenmeir AW, Howald WN, Baillie TA (1987) Cytochrome P-450 catalysed formation of Δ4, a toxic metabolite of valproic acid. Science 235:890–893
Rötig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, Schmitz J, Rustin P, Fischer A, Saudubray JM, Munnich A (1990) Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. Clin Invest 86:1601–1608
Rustin P, Chretien D, Bourgeron T, Wucher A, Saudubray JM, Rötig A, Munnich A (1991) Assessment of the mitochondrial respiratory chain. Lancet 338:60
Vassault A, Bonnefont JP, Specola N, Saudubray JM (1991) Lactate, pyruvate and ketone bodies. In: Homme FA (ed) Techniques in diagnostic human biochemical genetics. A laboratory manual. Wiley-Liss, New York, pp 285–308
Willmore LJ, Triggs WJ, Pellock JM (1991) Valproate toxicity: risk-screening strategies. J Child Neurol 6:3–6
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chabrol, B., Mancini, J., Chretien, D. et al. Valproate-induced hepatic failure in a case of cytochromec oxidase deficiency. Eur J Pediatr 153, 133–135 (1994). https://doi.org/10.1007/BF01959226
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01959226